<?xml version="1.0" encoding="UTF-8" standalone="no"?><document setID="2d545c2f-29a4-432f-bea9-2aeda6592a62"><labelDrug name="Tekturna HCT"><Normalization><mmtx cui="C2241884" preferredWord="Tekturna HCT" semType="phsu, orch"/></Normalization></labelDrug><generic name="aliskiren hemifumarate and hydrochlorothiazide"/><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1" text="Drug Label for drug brand Tekturna HCT, containing aliskiren hemifumarate and hydrochlorothiazide." type="negative"><entity charOffset="0:19" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.0" text="drug drug" type="Biomedical_Entity"><Normalization><mmtx cui="C0013231" phraseText="Drug Label for drug brand Tekturna HCT," preferredWord="Drugs, Non-Prescription" semType="phsu"/><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="51:73" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.1" text="aliskiren hemifumarate" type="Biomedical_Entity"><Normalization><mmtx cui="C1879678" phraseText="aliskiren hemifumarate" preferredWord="aliskiren hemifumarate" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="26:38" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.2" text="tekturna hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2241884" phraseText="Drug Label for drug brand Tekturna HCT," preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="78:97" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.3" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide." preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.1"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.2"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.3"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.1"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.1" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.3"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.1.e.3"/></sentence><sentence biomedicalEntities="3" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13" lineNumber="28" text="Do not use aliskiren with ARBs or ACEIs in patients with diabetes see Warnings and Precautions (5.2), Clinical Studies (14.4)." type="regular"><entity charOffset="0:10" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.1" text="Do not use" type="Caution_Interaction"/><entity charOffset="34:39" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.2" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="57:65" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.3" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="11:20" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren with ARBs" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="26:30" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.5" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.4"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.3" ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.2" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.1" type="Caution_Interaction"/><pair context="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.3" ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.5" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.5" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.13.e.2"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.14" text="Because of the hydrochlorothiazide component, Tekturna HCT is contraindicated in patients with anuria or hypersensitivity to sulfonamide-derived drugs see Warnings and Precautions (5.6) and Adverse Reactions (6.1). " type="negative"><entity charOffset="125:136" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.14.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C3536763" phraseText="hypersensitivity to sulfonamide-derived drugs" preferredWord="Sulfonamide [EPC]" semType="phsu"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="46:58" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.14.e.1" text="tekturna hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2241884" phraseText="Tekturna HCT" preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="15:34" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.14.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Because of the hydrochlorothiazide component," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.14.e.1" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.14.e.0"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.14.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.14.e.0"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.14.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.14.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16" lineNumber="30" text="Do not use with angiotensin receptor blockers (ARBs) or ACE inhibitors (ACEIs) in patients with diabetes (4)" type="irregular"><entity charOffset="0:10" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.1" text="Do not use" type="Caution_Interaction"/><entity charOffset="16:45" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.2" text="angiotensin receptor blockers" type="Drug_Class"><Normalization><mmtx cui="C0521942" phraseText="use with angiotensin receptor blockers (ARBs)" preferredWord="Angiotensin II receptor antagonist" semType="phsu"/><mmtx cui="C0815017" phraseText="use with angiotensin receptor blockers (ARBs)" preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="56:70" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.3" text="ACE inhibitors" type="Drug_Class"><Normalization><mmtx cui="C0003015" phraseText="ACE inhibitors (ACEIs) in patients" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="96:104" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.4" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.3"/></relation><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.4"/></relation><relation type="hasObject"><labelDrug text="Tekturna HCT"/><normalization><mmtx><preferredWord>Tekturna HCT</preferredWord><phraseText>Tekturna HCT</phraseText><cuiCode>C2241884</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.16.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20" lineNumber="39" text="&lt;item&gt;Avoid concomitant use with ARBs or ACEIs in patients with renal impairment (GFR 60 mL/min) (5.2)." type="irregular"><entity charOffset="6:11" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="64:80" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.2" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><entity charOffset="41:46" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.3" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="33:37" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.4" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.1"><relations><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.4"/></relation><relation type="hasObject"><labelDrug text="Tekturna HCT"/><normalization><mmtx><preferredWord>Tekturna HCT</preferredWord><phraseText>Tekturna HCT</phraseText><cuiCode>C2241884</cuiCode><semType>phsu</semType><semType>orch</semType></mmtx></normalization></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.20.e.4"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.37" text="Thiazides cross the placenta, and use of thiazides during pregnancy is associated with a risk of fetal or neonatal jaundice, thrombocytopenia, and possible other adverse reactions that have occurred in Tekturna HCT." type="negative"><entity charOffset="202:214" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.37.e.0" text="tekturna hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2241884" phraseText="occurred in Tekturna HCT." preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="41:50" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.37.e.1" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="use of thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="0:9" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.37.e.2" text="thiazides" type="Biomedical_Entity"><Normalization><mmtx cui="C0541746" phraseText="Thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.37.e.1" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.37.e.0"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.37.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.37.e.0"/></sentence><sentence biomedicalEntities="3" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38" lineNumber="62" text="5.2 Renal Impairment/Hyperkalemia/Hypotension when Tekturna HCT is given in combination with ARBs or ACEIs" type="regular"><entity charOffset="21:33" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.1" text="Hyperkalemia" type="Specific_Interaction"/><entity charOffset="51:63" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.2" text="Tekturna HCT" type="Drug"><Normalization><mmtx cui="C2241884" phraseText="Tekturna HCT" preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="93:97" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.3" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="101:106" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.4" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="34:45" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.6" text="Hypotension" type="Specific_Interaction"/><entity charOffset="4:20" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.8" text="Renal Impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="5.2 Renal Impairment/Hyperkalemia/Hypotension" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="5.2 Renal Impairment/Hyperkalemia/Hypotension" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.ddi.2"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.6"><relations><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.4"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.ddi.3"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.8"><relations><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.3" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.4" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.3" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.38.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39" lineNumber="64" text="Tekturna HCT is contraindicated in patients with diabetes who are receiving ARBs or ACEIs because of the increased risk of renal impairment, hyperkalemia, and hypotension see Contraindications (4) and Clinical Studies (14.4)." type="regular"><entity charOffset="16:31" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.1" text="contraindicated" type="Caution_Interaction"/><entity charOffset="76:80" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.2" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="49:57" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.3" text="diabetes" type="SPAN"><Normalization><mmtx cui="C0011847" phraseText="with diabetes" preferredWord="Diabetes" semType="dsyn"/><mmtx cui="C0011849" phraseText="with diabetes" preferredWord="Diabetes Mellitus" semType="dsyn"/></Normalization></entity><entity charOffset="84:89" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.4" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="16:31" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.5" text="contraindicated" type="SPAN"/><entity charOffset="0:12" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.6" text="Tekturna HCT" type="Drug"><Normalization><mmtx cui="C2241884" phraseText="Tekturna HCT" preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="141:153" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.8" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="159:170" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.10" text="hypotension" type="Specific_Interaction"/><entity charOffset="123:139" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.12" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="ACEIs because of the increased risk of renal impairment," preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="ACEIs because of the increased risk of renal impairment," preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.2"/></relation><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.3"/></relation><relation type="hasSeverity"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.4"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.ddi.2"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.8"><relations><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.ddi.3"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.10"><relations><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.6"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.ddi.4"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.12"><relations><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.6"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.3" ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.6" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.2" severity="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.5" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.1" type="Caution_Interaction"/><pair context="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.3" ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.6" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.4" severity="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.5" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.39.e.4"/></sentence><sentence biomedicalEntities="3" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40" lineNumber="65" text="Avoid use of Tekturna HCT with ARBs or ACEIs in patients with moderate renal impairment (GFR 60 ml/min)." type="regular"><entity charOffset="0:5" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="39:44" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.2" text="ACEIs" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="31:35" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.3" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="13:25" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.4" text="Tekturna HCT" type="Drug"><Normalization><mmtx cui="C2241884" phraseText="use of Tekturna HCT" preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="71:87" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.5" text="renal impairment" type="SPAN"><Normalization><mmtx cui="C0035078" phraseText="with moderate renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="with moderate renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.5"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.5" ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.2" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.1" type="Caution_Interaction"/><pair context="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.5" ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.3" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.3" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.40.e.2"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.44" text="This may occur at any time during treatment and has occurred in patients with and without a history of angioedema with ACE inhibitors or angiotensin receptor antagonists. " type="negative"><entity charOffset="119:133" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.44.e.0" text="ace inhibitors" type="Biomedical_Entity"><Normalization><mmtx cui="C0003015" phraseText="with ACE inhibitors" preferredWord="Angiotensin-Converting Enzyme Inhibitors" semType="phsu"/><RxNorm RxCui="221294"/></Normalization></entity><entity charOffset="137:169" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.44.e.1" text="angiotensin receptor antagonists" type="Biomedical_Entity"><Normalization><mmtx cui="C0815017" phraseText="angiotensin receptor antagonists." preferredWord="Angiotensin Receptor Antagonists" semType="phsu"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.44.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.44.e.1"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.47" text="Patients who experience these effects, even without respiratory distress, require prolonged observation and appropriate monitoring measures since treatment with antihistamines and corticosteroids may not be sufficient to prevent respiratory involvement. " type="negative"><entity charOffset="161:175" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.47.e.0" text="antihistamines" type="Biomedical_Entity"><Normalization><mmtx cui="C0003360" phraseText="treatment with antihistamines" preferredWord="Antihistamines" semType="phsu, orch"/><RxNorm RxCui="967"/></Normalization></entity><entity charOffset="180:195" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.47.e.1" text="corticosteroids" type="Biomedical_Entity"><Normalization><mmtx cui="C0001617" phraseText="corticosteroids" preferredWord="Adrenal Cortex Hormones" semType="strd, phsu, horm"/><RxNorm RxCui="1427675"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.47.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.47.e.1"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.51" text="In patients with an activated renin-angiotensin system, such as volume- and/or salt-depleted patients receiving high doses of diuretics, symptomatic hypotension may occur. " type="negative"><entity charOffset="36:47" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.51.e.0" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="with an activated renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><entity charOffset="126:135" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.51.e.1" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="high doses of diuretics," preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.51.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.51.e.1"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.56" text="Changes in renal function, including acute renal failure, can be caused by drugs that affect the renin-angiotensin system and by diuretics. " type="negative"><entity charOffset="129:138" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.56.e.0" text="diuretics" type="Biomedical_Entity"><Normalization><mmtx cui="C0012798" phraseText="and by diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><entity charOffset="103:114" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.56.e.1" text="angiotensin" type="Biomedical_Entity"><Normalization><mmtx cui="C0003018" phraseText="the renin-angiotensin system" preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="839"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.56.e.1" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.56.e.0"/></sentence><sentence biomedicalEntities="4" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57" lineNumber="80" text="Patients whose renal function may depend in part on the activity of the renin-angiotensin system (e.g., patients with renal artery stenosis, severe heart failure, post-myocardial infarction or volume depletion) or patients receiving ARB, ACEI or non-steroidal anti-inflammatory (NSAID) therapy may be at particular risk of developing acute renal failure on Tekturna HCT see Contraindications (4), Warnings and Precautions (5.2), Clinical Studies (14.4). " type="regular"><entity charOffset="334:353" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.1" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="be at particular risk of developing acute renal failure" preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><entity charOffset="233:236" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.2" text="ARB" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="246:293" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.3" text="non-steroidal anti-inflammatory (NSAID) therapy" type="Drug_Class"><Normalization><mmtx cui="C0003209" phraseText="non-steroidal anti-inflammatory (NSAID) therapy" preferredWord="Anti-Inflammatory Agents" semType="phsu"/><RxNorm RxCui="1005832"/></Normalization></entity><entity charOffset="357:369" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.4" text="Tekturna HCT" type="Drug"><Normalization><mmtx cui="C2241884" phraseText="on Tekturna HCT" preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="238:242" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.5" text="ACEI" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.5"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.4" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.3" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.4" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.1" type="Specific_Interaction"/><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.5" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.4" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.1" type="Specific_Interaction"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.3"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.5"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.5" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.57.e.3"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.65" lineNumber="93" text="Lithium generally should not be given with thiazides see Drug Interactions (7)." type="regular"><entity charOffset="25:37" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.65.e.1" text="not be given" type="Caution_Interaction"/><entity charOffset="43:52" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.65.e.2" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="given with thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="0:7" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.65.e.3" text="Lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Lithium generally" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.65.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.65.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.65.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.65.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.65.e.3" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.65.e.2" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.65.e.1" type="Caution_Interaction"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.68" text="In the short-term controlled trials of various doses of Tekturna HCT, in patients with hypertension not concomitantly treated with an ARB or ACEI, the incidence of hypertensive patients who developed hypokalemia (serum potassium 3.5 mEq/L) was 2.2%, the incidence of hyperkalemia (serum potassium 5.5 mEq/L) was 0.8%. " type="negative"><entity charOffset="287:296" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.68.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="(serum potassium 5.5 mEq/" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="219:228" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.68.e.1" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="(serum potassium 3.5 mEq/" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="56:68" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.68.e.2" text="tekturna hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2241884" phraseText="of Tekturna HCT," preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.68.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.68.e.0"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.68.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.68.e.1"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.70" text="Monitor serum potassium periodically in patients receiving aliskiren. " type="negative"><entity charOffset="14:23" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.70.e.0" text="potassium" type="Biomedical_Entity"><Normalization><mmtx cui="C0597277" phraseText="Monitor serum potassium periodically in patients" preferredWord="Potassium Ion" semType="phsu, elii"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="59:68" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.70.e.1" text="aliskiren" type="Biomedical_Entity"><Normalization><mmtx cui="C1120110" phraseText="aliskiren." preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.70.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.70.e.1"/></sentence><sentence biomedicalEntities="5" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72" lineNumber="99" text="Risk factors for the development of hyperkalemia include renal insufficiency, diabetes, combination use with ARBs or ACEI see Contraindications (4), Warnings and Precautions (5.2), and Clinical Studies (14.4), NSAIDs, or potassium supplements or potassium sparing diuretics." type="irregular"><entity charOffset="36:48" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.1" text="hyperkalemia" type="Specific_Interaction"/><entity charOffset="246:273" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.2" text="potassium sparing diuretics" type="Drug_Class"><Normalization><mmtx cui="C0304490" phraseText="potassium sparing diuretics." preferredWord="Potassium Sparing Diuretics" semType="phsu"/><RxNorm RxCui="8588"/></Normalization></entity><entity charOffset="210:216" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="117:121" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.4" text="ACEI" type="Drug_Class"><Normalization><RxNorm RxCui="NA"/></Normalization></entity><entity charOffset="109:113" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.5" text="ARBs" type="Drug_Class"><Normalization><RxNorm RxCui="1149617"/></Normalization></entity><entity charOffset="221:242" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.6" text="potassium supplements" type="Drug_Class"><Normalization><mmtx cui="C0304475" phraseText="potassium supplements" preferredWord="Potassium supplement" semType="inch, phsu"/><RxNorm RxCui="8588"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.4"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.70" text="Monitor serum potassium periodically in patients receiving aliskiren. "><entity charOffset="59:68" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.70.e.0" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren." preferredWord="aliskiren" semType="phsu, orch"/></Normalization></entity></ellipsisSentence><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.71" text="Drugs that affect the renin-angiotensin system can cause hyperkalemia. "/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.5"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.6"/></relation></relations></interaction></drugInteraction><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.3" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.2"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.2"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.5" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.2"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.6" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.2"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.3"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.5" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.3"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.3" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.6"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.5" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.4"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.6"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.5" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.6"/><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.2"/><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.3"/><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.4"/><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.5"/><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.72.e.6"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.77" text="5.10 Cyclosporine or Itraconazole" type="negative"><entity charOffset="5:17" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.77.e.0" text="cyclosporine" type="Biomedical_Entity"><Normalization><mmtx cui="C0010592" phraseText="5.10 Cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="21:33" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.77.e.1" text="itraconazole" type="Biomedical_Entity"><Normalization><mmtx cui="C0064113" phraseText="Itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.77.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.77.e.1"/></sentence><sentence biomedicalEntities="3" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78" lineNumber="105" text="When aliskiren was given with cyclosporine or itraconazole, the blood concentrations of aliskiren were significantly increased. " type="regular"><entity charOffset="64:84|117:126" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.1" text="blood concentrations increased" type="Increase_Interaction"/><entity charOffset="46:58" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.2" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="itraconazole," preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="30:42" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.3" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="given with cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="88:97" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="the blood concentrations of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><mmtx cui="C1120110" phraseText="the blood concentrations of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.4" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.1" type="Increase_Interaction"/><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.3" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.4" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.1" type="Increase_Interaction"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.3" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.78.e.2"/></sentence><sentence biomedicalEntities="3" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79" lineNumber="105" text="Avoid concomitant use of aliskiren with cyclosporine or itraconazole see Drug Interactions (7)." type="regular"><entity charOffset="0:5" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="40:52" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.2" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="with cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="56:68" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.3" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="25:34" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.4" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="concomitant use of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.3"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.2" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.1" type="Caution_Interaction"/><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.3" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.1" type="Caution_Interaction"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.79.e.3"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.81" text="Hydrochlorothiazide, a sulfonamide, can cause an idiosyncratic reaction, resulting in acute transient myopia and acute angle-closure glaucoma. " type="negative"><entity charOffset="23:34" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.81.e.0" text="sulfonamide" type="Biomedical_Entity"><Normalization><mmtx cui="C0599503" phraseText="a sulfonamide," preferredWord="Sulfonamide Anti-Infective Agents" semType="orch, antb"/><RxNorm RxCui="1427600"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.81.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide," preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.81.e.1" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.81.e.0"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.88" text="Hydrochlorothiazide may alter glucose tolerance and raise serum levels of cholesterol and triglycerides." type="negative"><entity charOffset="0:19" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.88.e.0" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="30:37" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.88.e.1" text="glucose" type="Biomedical_Entity"><Normalization><mmtx cui="C0017725" phraseText="glucose tolerance" preferredWord="Glucose" semType="bacs, phsu, carb"/><RxNorm RxCui="4850"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.88.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.88.e.1"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.90" text="Hydrochlorothiazide decreases urinary calcium excretion and may cause elevations of serum calcium. " type="negative"><entity charOffset="38:45" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.90.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="urinary calcium excretion" preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="90:97" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.90.e.1" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C2936886" phraseText="elevations of serum calcium." preferredWord="Calcium [EPC]" semType="phsu"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="0:19" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.90.e.2" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="Hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.90.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.90.e.0"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.90.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.90.e.1"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.91" text="Monitor calcium levels in patients with hypercalcemia receiving Tekturna HCT." type="negative"><entity charOffset="8:15" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.91.e.0" text="calcium" type="Biomedical_Entity"><Normalization><mmtx cui="C0006675" phraseText="Monitor calcium levels in patients" preferredWord="Calcium" semType="bacs, phsu, elii"/><RxNorm RxCui="1895"/></Normalization></entity><entity charOffset="64:76" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.91.e.1" text="tekturna hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2241884" phraseText="with hypercalcemia receiving Tekturna HCT." preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.91.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.91.e.1"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.93" text="No drug interaction studies have been conducted with Tekturna HCT and other drugs, although studies with the individual aliskiren and hydrochlorothiazide components are described below." type="negative"><entity charOffset="53:65" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.93.e.0" text="tekturna hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2241884" phraseText="conducted with Tekturna HCT" preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="134:153" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.93.e.1" text="hydrochlorothiazide" type="Biomedical_Entity"><Normalization><mmtx cui="C0020261" phraseText="hydrochlorothiazide components" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><entity charOffset="120:129" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.93.e.2" text="aliskiren" type="Biomedical_Entity"><Normalization><mmtx cui="C1120110" phraseText="studies with the individual aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.93.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.93.e.1"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.93.e.0" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.93.e.2"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.93.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.93.e.1"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.94" lineNumber="121" text="Cyclosporin e : Avoid co-administration of cyclosporine with aliskiren." type="regular"><entity charOffset="16:21" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.94.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="43:55" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.94.e.2" text="cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="co-administration of cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><entity charOffset="61:70" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.94.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="with aliskiren." preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.94.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.94.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.94.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.94.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.94.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.94.e.3" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.94.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.95" lineNumber="122" text="Itraconazole: Avoid co-administration of itraconazole with aliskiren See Clinical Pharmacology (12.3)." type="regular"><entity charOffset="14:19" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.95.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="41:53" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.95.e.2" text="itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="co-administration of itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><entity charOffset="59:68" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.95.e.3" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="with aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.95.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.95.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.95.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.95.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.95.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.95.e.3" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.95.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96" lineNumber="123" text="Non-Steroidal Anti-Inflammatory Agents (NSAIDs) including selective Cyclooxygenase-2 inhibitors (COX-2 inhibitors): In patients who are elderly, volume-depleted (including those on diuretic therapy), or with compromised renal function, co-administration of NSAIDs, including selective COX-2 inhibitors with agents that affect the renin-angiotensin system, including aliskiren, may result in deterioration of renal function, including possible acute renal failure. " type="regular"><entity charOffset="257:263" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.1" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="co-administration of NSAIDs," preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="275:301" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.2" text="selective COX-2 inhibitors" type="Drug_Class"><Normalization><mmtx cui="C1257954" phraseText="selective COX-2 inhibitors with agents" preferredWord="Cyclooxygenase 2 Inhibitors" semType="phsu, orch"/><RxNorm RxCui="1431714"/></Normalization></entity><entity charOffset="307:354" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.4" text="agents that affect the renin-angiotensin system" type="Drug_Class"><Normalization><mmtx cui="C1254351" phraseText="selective COX-2 inhibitors with agents" preferredWord="Pharmacologic Substance" semType="phsu"/><mmtx cui="C0035100" phraseText="the renin-angiotensin system," preferredWord="Chymosin" semType="phsu, aapp, enzy"/><mmtx cui="C0003018" phraseText="the renin-angiotensin system," preferredWord="Angiotensins" semType="bacs, phsu, aapp"/><RxNorm RxCui="126263"/></Normalization></entity><entity charOffset="366:375" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.5" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren," preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="391:422" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.7" text="deterioration of renal function" type="Specific_Interaction"/><entity charOffset="208:234" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.8" text="compromised renal function" type="SPAN"/><entity charOffset="145:160" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.9" text="volume-depleted" type="SPAN"/><entity charOffset="136:143" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.10" text="elderly" type="SPAN"/><entity charOffset="443:462" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.12" text="acute renal failure" type="Specific_Interaction"><Normalization><mmtx cui="C0022660" phraseText="possible acute renal failure." preferredWord="Kidney Failure, Acute" semType="dsyn"/></Normalization></entity><classClassMembership drugClass="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.2"/><drugClassMembership drug="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.5" drugClass="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.4"/><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.7"><relations><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.10"/></relation><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.9"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.1"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.ddi.2"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.12"><relations><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.8"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.4"/></relation><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.10"/></relation><relation type="hasContext"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.9"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.1"/></relation></relations></interaction></drugInteraction><pair context="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.8, Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.10, Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.9" ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.1" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.4" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.96.e.7" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.98" lineNumber="123" text="Monitor renal function periodically in patients receiving aliskiren and NSAID therapy." type="regular"><entity charOffset="0:7" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.98.e.1" text="Monitor" type="Caution_Interaction"/><entity charOffset="58:67" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.98.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="72:77" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.98.e.3" text="NSAID" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="NSAID therapy." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.98.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.98.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.98.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.98.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.98.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.98.e.3" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.98.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.99" lineNumber="124" text="The antihypertensive effect of aliskiren may be attenuated by NSAIDs." type="regular"><entity charOffset="4:27|48:58" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.99.e.1" text="antihypertensive effect attenuated" type="Specific_Interaction"/><entity charOffset="31:40" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.99.e.2" text="aliskiren" type="Drug"><Normalization><mmtx cui="C1120110" phraseText="The antihypertensive effect of aliskiren" preferredWord="aliskiren" semType="phsu, orch"/><RxNorm RxCui="325646"/></Normalization></entity><entity charOffset="62:68" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.99.e.3" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="attenuated by NSAIDs." preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.99.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.99.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.99.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.99.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.99.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.99.e.3" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.99.e.1" type="Specific_Interaction"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.101" lineNumber="126" text="Antidiabetic drugs (oral agents and insulin ) : Dosage adjustment of the antidiabetic drug may be required." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="73:90" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.101.e.1" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="0-31" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.101.e.2" text="Antidiabetic drugs oral agents" type="Drug_Class"/></anaphoraRelation><anaphoraRelation><anaphoraEntity charOffset="73:90" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.101.e.1" text="antidiabetic drug" type="Expression"/><antecedentEntity charOffset="36-43" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.101.e.4" text="insulin" type="Drug"/></anaphoraRelation><entity charOffset="0:18|20:31" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.101.e.2" text="Antidiabetic drugs oral agents" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="Antidiabetic drugs" preferredWord="Antidiabetics" semType="phsu"/><mmtx cui="C1254351" phraseText="(oral agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><entity charOffset="36:43" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.101.e.4" text="insulin" type="Drug"><Normalization><mmtx cui="C0021641" phraseText="insulin" preferredWord="Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1533581" phraseText="insulin" preferredWord="Recombinant Insulin" semType="phsu, aapp, horm"/><mmtx cui="C1579433" phraseText="insulin" preferredWord="Insulin [EPC]" semType="phsu"/><RxNorm RxCui="5856"/></Normalization></entity><entity charOffset="48:65" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.101.e.6" text="Dosage adjustment" type="Caution_Interaction"/><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.101.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.101.e.6"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.100" text="When administered concurrently, the following drugs may interact with thiazide diuretics."><entity charOffset="70:88" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.100.e.0" text="thiazide diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012802" phraseText="interact with thiazide diuretics." preferredWord="Thiazide Diuretics" semType="phsu, orch"/></Normalization></entity></ellipsisSentence></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.101.e.1"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102" lineNumber="127" text="Lithium : Diuretic agents increase the risk of lithium toxicity. " type="regular"><entity charOffset="55:63" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102.e.1" text="toxicity" type="Increase_Interaction"/><entity charOffset="47:54" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="the risk of lithium toxicity." preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="10:25" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102.e.3" text="Diuretic agents" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="Diuretic agents" preferredWord="Diuretics" semType="phsu"/><mmtx cui="C1254351" phraseText="Diuretic agents" preferredWord="Pharmacologic Substance" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102.e.3" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102.e.2" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102.e.1" type="Increase_Interaction"/></sentence><sentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.103" text="Refer to the package insert for lithium before use of such preparation with Tekturna HCT. " type="negative"><entity charOffset="76:88" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.103.e.0" text="tekturna hct" type="Biomedical_Entity"><Normalization><mmtx cui="C2241884" phraseText="with Tekturna HCT." preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><entity charOffset="32:39" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.103.e.1" text="lithium" type="Biomedical_Entity"><Normalization><mmtx cui="C0023870" phraseText="for lithium" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.103.e.1" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.103.e.0"/></sentence><sentence biomedicalEntities="1" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.104" lineNumber="127" text="Monitoring of serum lithium concentrations is recommended during concurrent use." type="irregular"><entity charOffset="0:10" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.104.e.1" text="Monitoring" type="Caution_Interaction"/><entity charOffset="20:27" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.104.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C1441405" phraseText="Monitoring of serum lithium concentrations" preferredWord="Lithium.serum" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.104.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.104.e.1"><relations><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102" text="Lithium : Diuretic agents increase the risk of lithium toxicity. "><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.102.e.3"/></ellipsisSentence><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.103" text="Refer to the package insert for lithium before use of such preparation with Tekturna HCT. "/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.104.e.2"/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="2" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105" lineNumber="128" text="Nonsteroidal anti-inflammatory d rugs : When Tekturna HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained." type="regular"><entity charOffset="146:154" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.1" text="observed" type="Caution_Interaction"/><entity charOffset="62:99" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.2" text="nonsteroidal anti-inflammatory agents" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="nonsteroidal anti-inflammatory agents" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="402125"/></Normalization></entity><entity charOffset="45:57" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.3" text="Tekturna HCT" type="Drug"><Normalization><mmtx cui="C2241884" phraseText="Tekturna HCT" preferredWord="Tekturna HCT" semType="phsu, orch"/><RxNorm RxCui="700402"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.3" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.2" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.1" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="4" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106" lineNumber="129" text="Ion exchange resins: Staggering the dosage of hydrochlorothiazide and ion exchange resins (e.g., cholestyramine, colestipol) such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins would potentially minimize the interaction see Clinical Pharmacology (12.3)." type="regular"><entity charOffset="70:89" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.1" text="ion exchange resins" type="Drug_Class"><Normalization><mmtx cui="C0022014" phraseText="ion exchange resins" preferredWord="Ion Exchange Resins" semType="phsu, irda, bodm"/><RxNorm RxCui="1239134"/></Normalization></entity><entity charOffset="97:111" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.2" text="cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="cholestyramine," preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><entity charOffset="113:123" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.4" text="colestipol" type="Drug"><Normalization><mmtx cui="C0009279" phraseText="colestipol" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="21:42" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.6" text="Staggering the dosage" type="Caution_Interaction"><Normalization><mmtx cui="C0344191" phraseText="Staggering" preferredWord="Cerebellar decompression injury" semType="dsyn"/></Normalization></entity><entity charOffset="46:65" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.7" text="hydrochlorothiazide" type="Drug"><Normalization><mmtx cui="C0020261" phraseText="the dosage of hydrochlorothiazide" preferredWord="Hydrochlorothiazide" semType="phsu, orch"/><RxNorm RxCui="5487"/></Normalization></entity><drugClassMembership drug="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.2" drugClass="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.1"/><drugClassMembership drug="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.4" drugClass="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.1"/><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.6"><relations><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.7"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.1"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.7" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.1" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106.e.6" type="Caution_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.107" lineNumber="132" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)." type="irregular"><entity charOffset="20:25" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.107.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="6:18" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.107.e.2" text="Cyclosporine" type="Drug"><Normalization><mmtx cui="C0010592" phraseText="&gt;Cyclosporine" preferredWord="Cyclosporine" semType="phsu, aapp"/><RxNorm RxCui="3008"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.107.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.107.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.107.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105" text="Nonsteroidal anti-inflammatory d rugs : When Tekturna HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained."><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.3"/></ellipsisSentence><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106" text="Ion exchange resins: Staggering the dosage of hydrochlorothiazide and ion exchange resins (e.g., cholestyramine, colestipol) such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins would potentially minimize the interaction see Clinical Pharmacology (12.3)."/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.107.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.108" lineNumber="134" text="&lt;item&gt;Itraconazole: Avoid concomitant use (7, 12.3)" type="irregular"><entity charOffset="20:25" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.108.e.1" text="Avoid" type="Caution_Interaction"/><entity charOffset="6:18" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.108.e.2" text="Itraconazole" type="Drug"><Normalization><mmtx cui="C0064113" phraseText="&gt;Itraconazole" preferredWord="Itraconazole" semType="phsu, orch"/><RxNorm RxCui="28031"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.108.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.108.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.108.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105" text="Nonsteroidal anti-inflammatory d rugs : When Tekturna HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained."><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.3"/></ellipsisSentence><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106" text="Ion exchange resins: Staggering the dosage of hydrochlorothiazide and ion exchange resins (e.g., cholestyramine, colestipol) such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins would potentially minimize the interaction see Clinical Pharmacology (12.3)."/><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.107" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)."/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.108.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109" lineNumber="136" text="&lt;item&gt;NSAIDs use may lead to increased risk of renal impairment and loss of antihypertensive effect (7)." type="irregular"><entity charOffset="68:99" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109.e.1" text="loss of antihypertensive effect" type="Specific_Interaction"/><entity charOffset="6:12" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109.e.2" text="NSAIDs" type="Drug_Class"><Normalization><mmtx cui="C0003211" phraseText="&gt;NSAIDs" preferredWord="Anti-Inflammatory Agents, Non-Steroidal" semType="phsu"/><RxNorm RxCui="889"/></Normalization></entity><entity charOffset="47:63" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109.e.4" text="renal impairment" type="Specific_Interaction"><Normalization><mmtx cui="C0035078" phraseText="lead to increased risk of renal impairment" preferredWord="Kidney Failure" semType="dsyn"/><mmtx cui="C0341697" phraseText="lead to increased risk of renal impairment" preferredWord="Renal impairment" semType="dsyn"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105" text="Nonsteroidal anti-inflammatory d rugs : When Tekturna HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained."><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.3"/></ellipsisSentence><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106" text="Ion exchange resins: Staggering the dosage of hydrochlorothiazide and ion exchange resins (e.g., cholestyramine, colestipol) such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins would potentially minimize the interaction see Clinical Pharmacology (12.3)."/><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.107" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)."/><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.108" text="&lt;item&gt;Itraconazole: Avoid concomitant use (7, 12.3)"/></relation></relations></interaction></drugInteraction><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109.ddi.2"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109.e.4"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109.e.2"/></relation><relation type="hasObject"><ellipsisSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105" text="Nonsteroidal anti-inflammatory d rugs : When Tekturna HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained."><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.3"/></ellipsisSentence><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106" text="Ion exchange resins: Staggering the dosage of hydrochlorothiazide and ion exchange resins (e.g., cholestyramine, colestipol) such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins would potentially minimize the interaction see Clinical Pharmacology (12.3)."/><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.107" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)."/><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.108" text="&lt;item&gt;Itraconazole: Avoid concomitant use (7, 12.3)"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="labelDrug" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109.e.2"/></sentence><sentence biomedicalEntities="1" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.110" lineNumber="138" text="&lt;item&gt;Antidiabetic Drugs: Dosage adjustment of antidiabetic may be required (7)." type="irregular"><anaphoraRelation><anaphoraEntity charOffset="47:59" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.110.e.2" text="antidiabetic" type="Expression"/><antecedentEntity charOffset="6-24" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.110.e.4" text="Antidiabetic Drugs" type="Drug_Class"/></anaphoraRelation><entity charOffset="26:43" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.110.e.1" text="Dosage adjustment" type="Caution_Interaction"/><entity charOffset="6:24" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.110.e.4" text="Antidiabetic Drugs" type="Drug_Class"><Normalization><mmtx cui="C0935929" phraseText="&gt;Antidiabetic Drugs" preferredWord="Antidiabetics" semType="phsu"/><RxNorm RxCui="282360"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.110.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.110.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.110.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105" text="Nonsteroidal anti-inflammatory d rugs : When Tekturna HCT and nonsteroidal anti-inflammatory agents are used concomitantly, the patient should be observed closely to determine if the desired effect of the diuretic is obtained."><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.105.e.3"/></ellipsisSentence><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.106" text="Ion exchange resins: Staggering the dosage of hydrochlorothiazide and ion exchange resins (e.g., cholestyramine, colestipol) such that hydrochlorothiazide is administered at least 4 hours before or 4-6 hours after the administration of resins would potentially minimize the interaction see Clinical Pharmacology (12.3)."/><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.107" text="&lt;item&gt;Cyclosporine: Avoid concomitant use (7, 12.3)."/><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.108" text="&lt;item&gt;Itraconazole: Avoid concomitant use (7, 12.3)"/><middleSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.109" text="&lt;item&gt;NSAIDs use may lead to increased risk of renal impairment and loss of antihypertensive effect (7)."/></relation></relations></interaction></drugInteraction></sentence><sentence biomedicalEntities="3" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111" lineNumber="140" text="&lt;item&gt;Cholestyramine and Colestipol: Reduced absorption of thiazides (7)." type="regular"><entity charOffset="37:55" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.1" text="Reduced absorption" type="Decrease_Interaction"/><entity charOffset="25:35" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.2" text="Colestipol" type="Drug"><Normalization><mmtx cui="C0009279" phraseText="Colestipol" preferredWord="Colestipol" semType="phsu, orch"/><RxNorm RxCui="104485"/></Normalization></entity><entity charOffset="59:68" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.3" text="thiazides" type="Drug_Class"><Normalization><mmtx cui="C0541746" phraseText="Reduced absorption of thiazides" preferredWord="Thiazides" semType="phsu, orch"/><RxNorm RxCui="141801"/></Normalization></entity><entity charOffset="6:20" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.4" text="Cholestyramine" type="Drug"><Normalization><mmtx cui="C0008402" phraseText="&gt;Cholestyramine" preferredWord="Cholestyramine Resin" semType="phsu, orch"/><RxNorm RxCui="2447"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.1"><relations><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.2"/></relation><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.3"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.4"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.3" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.1" type="Decrease_Interaction"/><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.3" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.1" type="Decrease_Interaction"/><pair ddi="false" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.4" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.111.e.2"/></sentence><sentence biomedicalEntities="2" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112" lineNumber="142" text="&lt;item&gt;Lithium: Increased risk of lithium toxicity when used with diuretics. " type="regular"><entity charOffset="41:49" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112.e.1" text="toxicity" type="Increase_Interaction"/><entity charOffset="33:40" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C0023870" phraseText="Increased risk of lithium toxicity" preferredWord="Lithium" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><entity charOffset="65:74" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112.e.3" text="diuretics" type="Drug_Class"><Normalization><mmtx cui="C0012798" phraseText="used with diuretics." preferredWord="Diuretics" semType="phsu"/><RxNorm RxCui="3567"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112.e.2"/></relation><relation type="hasPrecipitant"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112.e.3"/></relation></relations></interaction></drugInteraction><pair ddi="true" e1="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112.e.2" e2="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112.e.3" trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112.e.1" type="Increase_Interaction"/></sentence><sentence biomedicalEntities="1" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.113" lineNumber="142" text="Monitor serum lithium concentrations during concurrent use. " type="irregular"><entity charOffset="0:7" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.113.e.1" text="Monitor" type="Caution_Interaction"/><entity charOffset="14:21" id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.113.e.2" text="lithium" type="Drug"><Normalization><mmtx cui="C1441405" phraseText="Monitor serum lithium concentrations during concurrent use." preferredWord="Lithium.serum" semType="phsu, elii"/><RxNorm RxCui="1428998"/></Normalization></entity><drugInteraction id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.113.ddi.1"><interaction trigger="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.113.e.1"><relations><relation type="hasObject"><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.113.e.2"/></relation><relation type="hasPrecipitant"><ellipsisSentence id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112" text="&lt;item&gt;Lithium: Increased risk of lithium toxicity when used with diuretics. "><entity id="Dailymed.2d545c2f-29a4-432f-bea9-2aeda6592a62.s.112.e.3"/></ellipsisSentence></relation></relations></interaction></drugInteraction></sentence><positiveExamples number="39"/><negativeExamples number="50"/></document>